Why the study?
The study was conducted to assess the clinical efficacy and appropriateness of simultaneous single-stage combined coronary stenting and closure of atrial septal defect.
Is simultaneous single-stage combined coronary stenting and endovascular closure of atrial septal defect safe and effective in adults?
Observational (n=6)
Is simultaneous single-stage combined coronary stenting and endovascular closure of atrial septal defect safe and effective in adults?
Simultaneous coronary stenting and endovascular ASD closure appears to be a safe and effective single-stage procedure that reduces hospital stay without additive risk.
May support single-stage feasibility in select adults; hypothesis-generating and requires larger prospective validation before practice change.
AIM: to assess clinical efficacy and expediency (appropriateness) of simultaneous single stage combined coronary stenting and closure of atrial septal defect. MATERIALS AND METHODS: Of total number of patients who underwent endovascular correction of atrial septal defect (ASD) (n=91), in 6 (6.6 %) the procedure of endovascular repair of secondary ASD was combined with performed at same session oronary stenting. Mean age of these patients was 63±6.4 years. Mean diameter of ASD according to transesophageal echocardiography was 13.7±3.1 мм (from 10 to 17 mm). Two patients had dysplasia of atrial septum with pronounced aneurysmal protrusion in the right atrial cavity. Estimate of coronary arteries (CA) involvement SYNTAX score was 14.5±4.9. RESULTS: At initial stage we performed coronary stenting, then ASD closure with occluder. Technical success of combined endovascular procedures was 100 %. Six ASD occluders were implanted in 6 patients. Mean occluder diameter was 21±7,3 mm. Immediately after occluder implantation complete defect closure was achieved in 5 cases, in one case small residual shunt was observed. CA stenting procedure, in one patient after successful recanalization of chronic CA occlusion, in all cases was fulfilled without complications. At control examination after 13.5±1.5 months complete closure of defects was preserved. In all cases significant reduction of right heart chambers occurred. According to echocardiography right atrial volume decreased from 48.6±5.6 to 32.6±3.3 cm3, right ventricular volume - from 45.2±5.1 to 33.4±3.8 cm3, systolic pulmonary pressure fell from 49.7±8.6 to 32.6±6.9 mm Hg. According to control coronary angiography good effect of endovascular procedures was preserved. Tolerance to exercise rose from 68.5±11.8 до 85.3±12.4 W. CONCLUSION: Same time CA stenting and endovascular ASD closure appears to be safe and effective procedure. The strategy used was not associated with additive risk for a patient and shortened duration of hospital stay.
No takes yet. Share an insight, caveat, or question.
Dg et al. (2019) conducted an observational in Atrial septal defect and coronary artery disease (n=6). Simultaneous coronary stenting and endovascular closure of atrial septal defect was evaluated on Technical success of combined endovascular procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: